* Your assessment is very important for improving the work of artificial intelligence, which forms the content of this project
Download Use of Myocardial Perfusion SPECT for Preoperative Risk
Electrocardiography wikipedia , lookup
Saturated fat and cardiovascular disease wikipedia , lookup
Cardiac contractility modulation wikipedia , lookup
Antihypertensive drug wikipedia , lookup
Remote ischemic conditioning wikipedia , lookup
Cardiovascular disease wikipedia , lookup
Management of acute coronary syndrome wikipedia , lookup
Annals of Nuclear Cardiology Vol. 1 No. 1 43-52 REVIEW ARTICLE Use of Myocardial Perfusion SPECT for Preoperative Risk Stratification of Non- Cardiac Surgery Jun Hashimoto, MD, Toshiki Kazama, MD, Yoshimi Nagata, MD, Yutaka Imai, MD Received: May 20, 2015/Revised manuscript received: June 28, 2015/Accepted: June 29, 2015 © The Japanese Society of Nuclear Cardiology 2015 Abstract It is difficult to assess the likelihood of perioperative cardiac events mainly because of complicated interrelationships between clinical risk and type of surgery. To overcome this problem, The American College of Cardiology/American Heart Association(ACC/AHA)Task Force published guidelines for perioperative cardiovascular evaluation for non-cardiac surgery. The guidelines offer the strategy of preoperative cardiac therapy, operative performance and perioperative management depending on the urgency of surgery, the patient$ s risk factors, findings of cardiac testing and specific surgical considerations. Non-invasive cardiac testing including myocardial perfusion single-photon emission computed tomography(SPECT)is recommended to be used mainly in patients with poor functional capacity, when the results will affect patient treatment and outcomes. In the current review, we summarized the use of stress myocardial perfusion SPECT referring to previous reports and our data, and provided the tips for indication of SPECT in preoperative risk stratification in non-cardiac surgery. Keywords: Myocardial perfusion SPECT, Perioperative cardiac event, Preioperative risk stratification Ann Nucl Cardiol 2015;1(1) :43-52 ardiac events are important causes of perioperative C mortality and morbidity in non-cardiac surgery. tive therapy, operative performance and perioperative Thus, cardiac risk should be stratified in individual cardiac testing including myocardial perfusion imaging patients who are to undergo surgery, but it is difficult to to be used mainly in patients with poor functional assess the likelihood of perioperative cardiac events capacity(<4 METs) . management. The guidelines recommend non-invasive mainly because of complicated interrelationships be- In the current review, we summarized the use of tween clinical risk and type of surgery. To overcome stress myocardial perfusion single-photon emission this problem, The American College of Cardiology/ computed tomography(SPECT)referring to previous American Heart Association(ACC/AHA)Task Force reports and our data, and provided the tips for indication published guidelines for perioperative cardiovascular of SPECT in preoperative risk stratification in non-car- evaluation for non-cardiac surgery(1-4) . These guide- diac surgery. lines divide clinical risk factors into major, intermediate and minor categories, and surgical procedures into high, Preoperative risk stratification in view of cardiac intermediate and low-risk types. These are then used to testing determine further preoperative examinations, preopera- doi:10.17996/ANC. 01.01.43 Jun Hashimoto, Toshiki Kazama, Yoshimi Nagata, Yutaka Imai Department of Radiology, Tokai University School of Medicine, Shimokasuya 143, Isehara, Kanagawa, Japan 259-1193 E-mail: [email protected] As mentioned above, preoperative risk stratification is ― 44 ― Hashimoto et al. Preoperative Risk Stratification Ann Nucl Cardiol 2015;1(1) :43-52 generally difficult mainly due to complicated interrela- SPECT in preoperative risk stratification tionships between clinical risk factors and type of Position of SPECT in risk stratification surgery. Preoperative stress myocardial perfusion Fig. 1 shows the stepwise cardiac evaluation and care imaging provides excellent negative predictive values in program for non-cardiac surgery appeared in the forecasting perioperative cardiac events(5) . We re- ACC/AHA Guidelines(3) . Except for the emergent ported that normal perfusion and wall motion ensure a surgery, patients with active cardiac conditions includ- very low likelihood of perioperative cardiac events in ing unstable coronary disease, decompensated heart intermediate and low-risk surgery(6) . Accurate identi- failure, significant arrhythmia or severe valvular heart fication of low risk patients facilitates reductions in cost disease, are recommended to undergo further cardiac and preoperative waiting time because low risk evaluation and/or treatment. When low-risk surgery is individuals can be exempted from further cardiac performed on a patient without active cardiac condi- testing, including catheterization, and proceed directly tions, incremental cardiac risk in undergoing surgery is to surgery. thought to be negligible. The patient who have a On the other hand, not only SPECT but also other functional capacity 4 METs or more can also proceed to modalities yield insufficient positive predictive values the planned surgery. Preoperative cardiac evaluation of mainly because of the relatively low frequency of patients other than the above is performed by consider- perioperative cardiac events(7) . In addition, periopera- ing the number of clinical risk factors, type of surgery tive mortality and morbidity are related to management and results of cardiac testing. Preoperative SPECT is of patients. Surgeons and anesthesiologists are not also considered to be used in this step. blinded to the results of preoperative cardiac testing. This availability of results has an influence on decisions Exercise or adenosine for stress testing regarding perioperative management of patients, which Exercise or pharmacological(adenosine)stress is could lower the cardiac event rate and underestimate used for myocardial perfusion SPECT to assess stress- the predictive accuracy of preoperative examinations induced ischemia. Exercise has advantages that stress is including SPECT. physiological and that exercise capacity can be an index Since it is generally difficult to perform a prospective associated with cardiac morbidity and mortality. In clinical trial for assessing the predictive value on addition, exercise myocardial SPECT allows information patients undergoing surgery especially when the test whether ischemia occurs within the patientI s work results are blinded, most studies of this kind is capacity or not. On the other hand, pharmacological retrospective. In such studies, authors analyzed the data stress has an advantage that ischemia can be induced obtained from patients who underwent preoperative even if the patientI s functional capacity is low. Since SPECT. Most of them were referred for SPECT because perioperative cardiac stress is not dependent on the of concern about perioperative cardiac risk. Thus, these patientI s activities of daily living, pharmacological stress patients do not epitomize the general population of non- is favorable especially in patients with insufficient cardiac surgery candidates in terms of the likelihood of functional capacity. cardiac events. This increases the rate of perioperative cardiac events. SPECT indices for risk stratification Furthermore, the effect of preoperative revasculariza- Electrocardiogram(ECG) -gated stress myocardial tion remains unclear. There are some papers showing perfusion SPECT yields information on myocardial that preoperative revascularization is ineffective to perfusion, cardiac function and left ventricular volumes. reduce the cardiac event rate(8,9) . However, the It offers various indices including the summed stress effect of preoperative revascularization depends on the score(SSS),summed rest score(SRS),summed differ- selection of patients undergoing revascularization. ence score(SDS),ejection fraction(EF),end-diastolic Further studies are required to clarify the usefulness of volume(EDV) , end-systolic volume(ESV),and so on. SPECT in identifying patients who receive prognostic SRS and SDS reflect the size of myocardial scar and the benefit from preoperative revascularization. amount of stress-induced ischemia, respectively. It has It is generally difficult to elucidate the cost-effective- been reported that SRS, SDS and SSS are associated ness of perioperative SPECT, because of relatively low with perioperative cardiac events(6,10-13).The SSS is frequency of perioperative cardiac events, high cost of thought to have a considerable prognostic value because examination and uncertainty of the effect of preopera- it reflects both scar and ischemia(6, 13) . tive revascularization as mentioned above. Differences between rest and stress functional variables Hashimoto et al. Preoperative Risk Stratification Ann Nucl Cardiol 2015;1(1) :43-52 Table 1 Clinical Risk Factors and Surgical Risk Grade Clinical risk Contents Major Unstable coronary syndromes; Decompensated heart failure; Significant arrythmias; Severe valvular disease Intermediate Mild angina pectoris; Prior myocardial infarction; Compensated or prior heart failure; Diabetes Mellitus; Renal insufficiency Advanced age; Abnormal ECG; Rhythm other than sinus; Low functional capacity; History of stroke; Hypertension Emergent major operations; Aortic and other major vascular surgery; Peripheral vascular surgery; Anticipated prolonged surgical procedures associated with large fluid shift and/or blood loss Carotid endarterectomy; Head and neck; Intraperitoneal and intrathoracic; Orthopedic; Prostate Endoscopic procedures; Superficial procedures; Cataract; Breast (cited from reference No. 2) Minor Surgical risk ― 45 ― High Intermediate Low are markers of stress-induced ischemia(14-16).However, disease, heart failure, or cerebrovascular disease, as the it is reported that a post-stress depression of EF was intermediate risk factors. It is pointed out that 4 to 6 not associated with perioperative cardiac events(6) . weeks are reasonable to wait to perform elective This is attributable to the use of pharmacological stress surgery after myocardial infarction, if a recent stress instead of exercise, and to the cohort undergoing test does not indicate residual myocardium at risk. preoperative SPECT. Exercise increases myocardial The minor category comprises advanced age(grea- oxygen consumption and facilitates the likelihood of ter than 70 years), abnormal ECG(LV hypertrophy, post-ischemic stunning. On the other hand, pharmacolo- left bundle-branch block, ST-T abnormalities) , rhythm gical stress causes ischemia through coronary steal that other than sinus, and uncontrolled systemic hyperten- develops mainly in patients with severe coronary sion. Although these are not proven to increase stenosis. Since preoperative SPECT is usually per- perioperative risk independently, the presence of formed as a screening procedure, only a limited part of multiple minor predictors might lead to a higher the patients have severe coronary artery disease suspicion of coronary artery disease. These are not (CAD) . Therefore, the EF depression after adenosine incorporated into the recommendations for treatment in infusion is thought to have limited prognostic value for the guidelines. this cohort. Risk of surgical procedures Clinical risk factors As indicated in Table 1, the ACC/AHA guidelines Many investigators have identified preoperative divide surgical procedures into high, intermediate and clinical markers related to postoperative cardiac events, low-risk types(3). The high-risk group mainly con- the most frequent being advanced age, hypertension, sists of vascular surgery, and the low-risk type diabetes, angina pectoris, arrhythmias, history of comprises superficial or minimally invasive procedures myocardial infarction, heart failure, prior coronary including endoscopic surgery. The remaining general artery bypass grafting(CABG)and abnormality in surgery is classified into the intermediate-risk group. electrocardiography(10,11,17-20).As shown in Table 1, Perioperative cardiac event rates expected are >5%, 1 the ACC/AHA guidelines divide clinical risk factors into to 5%, and <1%, corresponding to the high, intermediate major, intermediate and minor categories(3) . and low-risk surgery. The major category includes unstable coronary disease, decompensated heart failure, Although there have been enough data concerning significant the use of SPECT for preoperative risk stratification in arrhythmia and severe valvular heart disease listed as high and intermediate-risk surgery(3-24) , little are active cardiac conditions in Fig. 1. The presence of 1 or available about low-risk surgery(6,12,13), despite more of these conditions mandates intensive manage- recent widespread acceptance of minimally invasive ment and may result in delay or cancellation of surgery surgical techniques including endoscopy. Accumulating unless the surgery is emergent. prognostic data about operations associated with The guidelines selected diabetes mellitus(DM) , renal insufficiency, and the history of ischemic heart different levels of risk is useful especially when changing a surgical approach to minimally invasive one for ― 46 ― Hashimoto et al. Preoperative Risk Stratification Ann Nucl Cardiol 2015;1(1) :43-52 Fig. 1 Stepwise approach to preoperative cardiac assessment * : unstable coronary disease, decompensated heart failure, significant arrhythmia and severe valvular heart disease, **: indicated in Table 1, ***: diabetes mellitus, renal insufficiency, and the history of ischemic heart disease, heart failure, or cerebrovascular disease.(cited from reference No. 3) patients with a high estimated cardiac risk, because neural network generally allows lower computational such data show that cardiac risk is reduced by such burden and is reported to be more accurate in choices. We showed that gated myocardial perfusion predicting cardiac events for high-risk patients com- SPECT has an incremental prognostic value in in- pared with a logistic regression model(21) . termediate, but not in low-risk, non-cardiac surgery as indicated in Fig. 2(6) . We generated linear and support vector machine (SVM)classifiers, and evaluated their accuracies in predicting perioperative cardiac events in all types of Integrating information in preoperative risk strati- non-cardiac surgery including high, intermediate and fication low-risk procedures(13) . In addition, we estimated an Before surgery, we can obtain various kinds of incremental prognostic value of SPECT indices in each information, including clinical and surgical risk, and model. The SVM is a kind of supervised learning indices obtained from various preoperative examina- methodology that yields an appropriate discrimination tions as mentioned above. Consequently, it is important program by using data whose inputs and accurate to seek methods to integrate the above information in outputs are already known(training dataset). It first risk stratification. generates an N-dimensional hyperplane that best Some investigators used mathematical models to separates the training data into two different half provide the likelihood of perioperative cardiac events on spaces, and then classify unknown de novo data by the basis of clinical risk and SPECT findings(19,21) . determining the half space they belong to. We intro- They employed a Bayesian model or an artificial neural duced a SVM in preoperative risk stratification. In this network as a tool to calculate the expected cardiac event context, the above two half spaces equal to the two rates. Advantages of the Bayesian model are that it situations: the presence and absence of cardiac events, permits consideration of the procedure-specific institu- and the training dataset consists of data of each patient tional complication rate in the estimation of risk and that whose predictive variables and the prognostic outcome it is not necessary to assume independence between are already known. The hyperplane is determined by a variables included in the model(19) . The artificial cluster of data located near the border of the two spaces, Hashimoto et al. Preoperative Risk Stratification Ann Nucl Cardiol 2015;1(1) :43-52 ― 47 ― Fig. 2 Incremental value of information about myocardial perfusion or cardiac function in predicting all cardiac events Stratification with summed rest score(A),summed stress score(B),LVEF at rest(C),and LVEF after stress(D). In each panel, patients were divided into 4 subgroups with clinical risk factors and operation risk. In each subgroup, patients were sorted again into three groups(closed, hatched and unfilled bars)according to the following threshold values of SPECT indices. closed bar,(A)summed rest score>7,(B)summed stress score>9,(C)and(D)LVEF<45%; hatched bar,(A) 1<summed rest score<6,(B)1<summed stress score<8,(C)and(D)46%<LVEF<59%; unfilled bar,(A) summed rest score=0,(B)summed stress score=0,(C)and(D)LVEF>60%; *. p<0.05; **, p<0.01(comparison between the unfilled bar and others). The total numbers of patients are 1220 in(A)and(B), and 868 in(C)and(D). The threshold values(summed stress score=9. summed rest score=7, and LVEF=45%)were determined on the basis of the mean and standard deviation: approximately mean+s.d. in perfusion scores, and mean−s.d. in LVEF.(cited from reference No. 6) which are called support vectors. The SVM analysis was reduced by introducing SPECT indices(without selects the appropriate hyperplane to maximize the SPECT: 34.9%, with SPECT: 22.1%) , which means that margin between the hyperplane and support vectors. the analysis became stable. Among supervised learning methodologies, SVM is thought to be one of the most accurate techniques. This study included 1351 consecutive patients who Perioperative risk in specific group of patients Clinical markers related to cardiac events were referred for preoperative dipyridamole stress As mentioned above, various factors have been myocardial perfusion scintigraphy and underwent non- identified as preoperative clinical markers related to cardiac surgery. Predictors(the input candidates for postoperative cardiac events, including advanced age, the classifiers)comprise one operation risk, 13 clinical hypertension, diabetes, angina pectoris, arrhythmias, risk, 3 SPECT perfusion indices, and 3 SPECT functional history of myocardial infarction, congestive heart failure, indices. The results are indicated in Tables 2 and 3. In prior CABG and abnormal baseline electrocardiography predicting all cardiac events, the SVM models yielded (10,11,17-20). In this review, we focused on aging, favorable predictive performance compared with the diabetes and ECG abnormality as clinical risk factors linear models regardless of the use of SPECT results related to perioperative cardiac events. (Table 2) . The incremental prognostic value of SPECT was considerable in the linear model. In predicting hard events(Table 3) , the percentage of the support vector Aging Recently, the number of the aged undergoing surgical ― 48 ― Hashimoto et al. Preoperative Risk Stratification Table 2 Classifier SVM Ann Nucl Cardiol 2015;1(1) :43-52 Predicting All Cardiac Events Input variables Sensitivity(%) Specificity(%) AUC Clinical+SPECT 97.4 72.2 0.884 Clinical only 85.5 76.5 0.861 Linear Clinical+SPECT 67.1 75.4 0.748 Clinical only 72.4 62.4 0.677 AUC: area under the ROC curve, SVM: support vector machine-based classifier, Linear: linear classifier(cited from reference No. 13) Table 3 Predicting Hard Events Classifier SVM Input variables Sensitivity(%) Specificity(%) AUC Clinical+SPECT 92.9 86.2 0.892 Clinical only 85.7 76.7 0.867 Linear Clinical+SPECT 85.7 81.5 0.864 Clinical only 71.4 79.4 0.768 AUC: area under the ROC curve, SVM: support vector machine-based classifier, Linear: linear classifier(cited from reference No. 13) Preoperative diagnosis of ischemic heart disease is difficult in the elderly because of reduced physical activity resulting in the reduction of demand angina and suboptimal performance in exercise cardiac testing. In such patients, a pharmacological stress test incorporating myocardial perfusion SPECT or echocardiogram is often of greater diagnostic or prognostic accuracy (24-26). A number of investigators have pointed out that aging increases the likelihood of perioperative cardiac events in non-cardiac surgery, and that age is an independent predictor of perioperative events(10,17, Fig. 3 Influence of aging on perioperative cardiac risk Closed bar: aged 75 or more, unfilled bar: others, High: high-risk surgery, Intermediate: intermediate-risk surgery. In patients with abnormal SPECT, aging had an influence on perioperative cardiac risk.(cited from reference No. 11) 27,28). On the other hand, advanced age is listed as a minor clinical predictor in the ACC/AHA Guidelines (1-3).In these guidelines, minor predictors are defined as markers for cardiovascular disease that have not been proven to independently increase perioperative risk. In addition, some authors reported that advanced treatment increases corresponding with the extension of age is not an independent predictor of perioperative the lifespan. The frequency of epicardial coronary artery outcome(29,30). stenosis increases with advancing age. Cardiac risk Furthermore, it remains unclear whether the cause of factors, which are more often present in the elderly than increased perioperative cardiac risk is attributable to the younger population, are thought to facilitate the aging itself or to the associated cardiac risk factors and progression of epicardial coronary artery stenosis and to coronary disease. In our previous report(11), we affect the coronary microcirculatory function(22) . divided patients into different groups according to the Besides these vascular conditions, age-related cardiac age and SPECT findings to separate the influence of changes include decrease in contractility, increase in aging from that of associated coronary artery disease. stiffness and ventricular filling pressures, decrease in As indicated in Fig. 3, aging itself had no appreciable beta-adrenoceptor and beta-adrenoceptor-mediated influence on perioperative cardiac risk in patients with modulation of inotropy and chronotropy, increase in left normal myocardial perfusion. In contrast, in patients atrial pressure/size and action potential time, and with perfusion abnormality, cardiac event rate increases decrease in coronary flow reserve(23) . All of the above following aging, independently of other clinical variables. changes are possible candidates for explaining increased DM perioperative cardiac risk in the elderly. The prevalence of CAD is reported to be high in Ann Nucl Cardiol 2015;1(1) :43-52 Hashimoto et al. Preoperative Risk Stratification ― 49 ― Fig. 4 Surgical risk and event rate in diabetic patients High, Intermediate and Low denote high, intermediate and low-risk surgery, respectively. The event rate increased depending on surgical risk when patients manifested abnormal perfusion findings, while such tendency was not observed in patients with normal perfusion.(cited from reference No. 12) Fig. 5 Risk stratification by combining information about myocardial perfusion and cardiac function in diabetic patients Abnormal means the presence of abnormality in perfusion and/or wall motion. Combining information about myocardial perfusion and wall motion improved predictive value of cardiac events (cited from reference No. 12) diabetic patients(31-33) . The AHA pointed out that kinds of surgery will augment cardiac risk in asymp- patients with DM belong to the same high-risk category tomatic DM patients. As indicated in Fig. 4, the cardiac as patients with known CAD(34) . Furthermore, it is event did not occur when patients underwent low-risk reported that cardiac death is the prominent cause for surgery regardless of perfusion findings, indicating the the mortality in type II DM patients(35,36) . limited value of SPECT before low-risk surgery. Diabetic patients also have higher postoperative However, the DM patients undergoing high-risk cardiac mortality and morbidity rates than those operation should be of particular concern if they have without DM(37) . The leading causes of death in DM abnormal SPECT findings. patients undergoing non-cardiac surgery are related to cardiac complications(38) . However, up to 65% of ECG abnormality myocardial ischemia or infarction is clinically silent Stress ECG is often used for selecting patients with a (39-41) . It is important and difficult to stratify high probability of perioperative cardiac events because perioperative cardiac risk of DM patients because of the of its availability and low cost. The onset of a myocardial high prevalence of asymptomatic myocardial ischemia ischemic response at low exercise workload is associated or infarction that is not so easy to diagnose. Moreover, it with increased risk of perioperative cardiac events is reported that that clinical risk factors are not of (2,3).However, the usefulness of ECG for preoperative prognostic value in asymptomatic DM patients in risk assessment is still controversial. A prospective predicting perioperative cardiac events(42) . study showed that ST segment depression in exercise Myocardial SPECT is reported to have a prognostic ECG is an independent predictor of perioperative value in DM patients with cardiac disease undergoing cardiac complications(44) . On the other hand, some non-cardiac surgery(43) . However, it remains unclear papers clarified the superiority of myocardial perfusion whether SPECT is of prognostic value in DM patients imaging and limitation of exercise ECG in preoperative without overt cardiac symptoms. We investigated the risk stratification(45,46).Duke treadmill score(DTS) usefulness of clinical risk factors, DM indexes and ECG- is widely used for risk stratification in patients gated SPECT findings in stratifying perioperative undergoing treadmill test. It is reported that one third of cardiac risk(12) . The duration was the only DM index patients with high-risk DTS manifested normal SPECT of prognostic value. Normal myocardial SPECT findings findings and that such patients are associated with low ensure the low likelihood of perioperative cardiac events risk of cardiac events(47) . However, it is not easy to in DM patients without chest pain(Fig. 4) . Simul- routinely conduct stress myocardial SPECT within taneous assessment of myocardial perfusion and cardiac limited time before surgery and the problem of the function by using ECG-gated SPECT was proved to examination cost also exists. Although the ACC/AHA yield more accurate risk stratification(Fig. 5) . Guidelines recommend myocardial perfusion study in In clinical practice, it is also worthy investigating what patients with high cardiac risk estimated by stress ECG ― 50 ― Hashimoto et al. Preoperative Risk Stratification Ann Nucl Cardiol 2015;1(1) :43-52 Sources of Funding This research was partially supported by Grant-inAid Scientific Research(18790912)from the Ministry of Education, Culture, Sports, Science and Technology. Conflicts of Interest None Reprint requsts and correspondence: Jun Hashimoto, Department of Radiology, Tokai University School of Fig. 6 Risk stratification by combining information about myocardial perfusion and cardiac function in patients with positive findings in stress ECG Classification 1: combination of summed stress score and stress LVEF; Classification 2: combination of summed stress score and stress LVEDV. The numbers in parentheses are the number of patients with cardiac events/total number in the category. if it will change management, there seems to be limited number of reports about preoperative risk stratification with myocardial SPECT after sorting the patients with stress ECG(48) . We collected data of patients with positive findings in preoperative stress ECG from our SPECT database to clarify whether myocardial perfusion SPECT stratifies risk of perioperative cardiac events. We also assessed prognostic value of combining perfusion and functional data obtained with ECG gated SPECT. Combination of information about myocardial perfusion and cardiac function was successful in separating patients of high risk causing 55% of all cardiac events from others of low risk including more than 80% of all the patients(Fig. 6) . Conclusions In non-cardiac surgery, preoperative therapy, operative performance and perioperative management are determined by considering the urgency of surgery, patientI s risk factors, specific surgical risk and findings of cardiac testing including SPECT. Although myocardial perfusion SPECT has been used for risk stratification mainly in high-risk surgery, some investigators pointed out its prognostic value in intermediate-risk surgery. It is important to seek methods to evaluate perioperative risk by integrating information of clinical and surgical risk, and SPECT findings. Acknowledgments None Medicine, Shimokasuya 143, Isehara, Kanagawa, Japan 259-1193 E-mail:[email protected] References 1.Eagle KA, Brundage BH, Chaitman BR, et al. Guidelines for perioperative cardiovascular evaluation for noncardiac surgery. Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines( Committee on Perioperative Cardiovascular Evaluation for Noncardiac Surgery) . J Am Coll Cardiol 1996; 27: 910-48. 2.Eagle KA, Berger PB, Calkins H, et al. ACC/AHA guideline update for perioperative cardiovascular evaluation for noncardiac surgery-executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Update the 1996 Guidelines on Perioperative Cardiovascular Evaluation for Noncardiac Surgery) . J Am Coll Cardiol 2002; 39: 542-53. 3.Fleisher LA, Beckman JA, Brown KA, et al. ACC/AHA 2006 guideline update on perioperative cardiovascular evaluation for noncardiac surgery: focused update on perioperative beta-blocker therapy: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines(Writing Committee to Update the 2002 Guidelines on Perioperative Cardiovascular Evaluation for Noncardiac Surgery) developed in collaboration with the American Society of Echocardiography, American Society of Nuclear Cardiology, Heart Rhythm Society, Society of Cardiovascular Anesthesiologists, Society for Cardiovascular Angiography and Interventions, and Society for Vascular Medicine and Biology. J Am Coll Cardiol 2006; 47: 2343-55. 4.Fleisher LA, Fleischmann KE, Auerbach AD, et al. 2014 ACC/AHA guideline on perioperative cardiovascular evaluation and management of patients undergoing noncardiac surgery: executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Circulation 2014; 130: 2215-45. Hashimoto et al. Preoperative Risk Stratification Ann Nucl Cardiol 2015;1(1) :43-52 5.Shaw LJ, Eagle KA, Gersh BJ, Miller DD. Meta-analysis of intravenous dipyridamole-thallium-201 ― 51 ― late cardiac events. Am Heart J 1996; 131: 923-9. imaging 19.LI Italien GJ, Paul SD, Hendel RC, et al. Development and (1985 to 1994)and dobutamine echocardiography(1991 validation of a Bayesian model for perioperative cardiac to 1994)for risk stratification before vascular surgery. J risk assessment in a cohort of 1, 081 vascular surgical Am Coll Cardiol 1996; 27: 787-98. 6.Hashimoto J, Nakahara T, Bai J, Kitamura N, Kasamatsu T, Kubo A. Preoperative risk stratification with myocardial perfusion imaging in intermediate and low-risk non-cardiac surgery. Circ J 2007; 71: 1395-400. 7.Weinstein H, Steingart R. Myocardial perfusion imaging for preoperative risk stratification. J Nucl Med 2011; 52: 750-60. 8.Mason JJ, Owens DK, Harris RA, Cooke JP, Hlatky MA. The role of coronary angiography and coronary revascularization before noncardiac vascular surgery. JAMA 1995; 273: 1919-25. 9.McFalls EO, Ward HB, Moritz TE, et al. Coronaryartery revascularization before elective major vascular surgery. N Engl J Med 2004; 351: 2795-804. 10.Hashimoto J, Suzuki T, Nakahara T, Kosuda S, Kubo A. Preoperative risk stratification using stress myocardial perfusion scintigraphy with electrocardiographic gating. J Nucl Med 2003; 44: 385-90. 11.Bai J, Hashimoto J, Nakahara T, Suzuki T, Kubo A. Influence of ageing on perioperative cardiac risk in non-cardiac surgery. Age Ageing 2007; 36: 68-72. 12.Bai J, Hashimoto J, Nakahara T, Kitamura N, Suzuki T, Kubo A. Preoperative risk evaluation in diabetic patients without angina. Diabetes Res Clin Pract 2008; 81: 150-4. 13.Kasamatsu T, Hashimoto J, Iyatomi H, et al. Application of support vector machine classifiers to preoperative risk stratification with myocardial perfusion scintigraphy. Circ J 2008; 72: 1829-35. 14.Hashimoto J, Kubo A, Iwasaki R, et al. Gated single-photon emission tomography imaging protocol to evaluate myocardial stunning after exercise. Eur J Nucl Med 1999; 26: 1541-6. 15.Yoda S, Sato Y, Matsumoto N, et al. Incremental value of regional wall motion analysis immediately after exercise for the detection of single-vessel coronary artery disease: study by separate acquisition, dual-isotope ECGgated single-photon emission computed tomography. Circ J 2005; 69: 301-5. 16.Tanaka H, Chikamori T, Hida S, et al. Comparison of post-exercise and post- vasodilator stress myocardial stunning as assessed by electrocardiogram-gated single-photon emission computed tomography. Circ J 2005; 69: 1338-45. 17.Baron JF, Mundler O, Bertrand M, et al. Dipyridamolethallium scintigraphy and gated radionuclide angiography to assess cardiac risk before abdominal aortic surgery. N Engl J Med 1994; 330: 663-9. 18.Stratmann HG, Younis LT, Wittry MD, Amato M, Miller DD. Dipyridamole technetium-99m sestamibi myocardial tomography in patients evaluated for elective vascular surgery: prognostic value for perioperative and 20.Coley CM, Field TS, Abraham SA, Boucher CA, Eagle KA. Usefulness of dipyridamole-thallium scanning for preoperative evaluation of cardiac risk for nonvascular surgery. Am J Cardiol 1992; 69: 1280-5. 21.Heiba SI, Jacobson AF, Shattuc S, Ferreira MJ, Sharma PN, Cerqueira MD. The additive values of left ventricular function and extent of myocardium at risk to dipyridamole perfusion imaging for optimal risk stratification prior to vascular surgery. Nucl Med Commun 1999; 20: 887-94. 22.Gould KL, Ornish D, Scherwitz L, et al. Changes in myocardial perfusion abnormalities by positron emission tomography after long-term, intense risk factor modification. JAMA 1995; 274: 894-901. 23.Priebe HJ. The aged cardiovascular risk patient. Br J Anaesth 2000; 85: 763-78. 24.Dhond MR, Nguyen TT, Sabapathy R, Patrawala RA, Bommer WJ. Dobutamine stress echocardiography in preoperative and long-term postoperative risk assessment of elderly patients. Am J Geriatr Cardiol 2003; 12: 107-9, 12. 25.Hilton TC, Shaw LJ, Chaitman BR, Stocke KS, Goodgold HM, Miller DD. Prognostic significance of exercise thallium-201 testing in patients aged greater than or equal to 70 years with known or suspected coronary artery disease. Am J Cardiol 1992; 69: 45-50. 26.Shaw L, Chaitman BR, Hilton TC, et al. Prognostic value of dipyridamole thallium-201 imaging in elderly patients. J Am Coll Cardiol 1992; 19: 1390-8. 27.Ashton CM, Petersen NJ, Wray NP, et al. The incidence of perioperative myocardial infarction in men undergoing noncardiac surgery. Ann Intern Med 1993; 118: 504-10. 28.Kazmers A, Perkins AJ, Jacobs LA. Outcomes after abdominal aortic aneurysm repair in those>or=80 years of age: recent Veterans Affairs experience. Ann Vasc Surg 1998; 12: 106-12. 29.Browner WS, Li J, Mangano DT. In-hospital and longterm mortality in male veterans following noncardiac surgery. The Study of Perioperative Ischemia Research Group. JAMA 1992; 268: 228-32. 30.Reilly DF, McNeely MJ, Doerner D, et al. Self-reported exercise tolerance and the risk of serious perioperative complications. Arch Intern Med 1999; 159: 2185-92. 31.Morrish NJ, Stevens LK, Head J, Fuller JH, Jarrett RJ, Keen H. A prospective study of mortality among middle-aged diabetic patients(the London Cohort of the WHO Multinational Study of Vascular Disease in Diabetics)II: Associated risk factors. Diabetologia 1990; 33: 542-8. 32.Stamler J, Vaccaro O, Neaton JD, Wentworth D. candidates. J Am Coll Cardiol 1996; 27: 779-86. ― 52 ― Hashimoto et al. Preoperative Risk Stratification Ann Nucl Cardiol 2015;1(1) :43-52 Diabetes, other risk factors, and 12-yr cardiovascular 41.Rutter MK, Wahid ST, McComb JM, Marshall SM. mortality for men screened in the Multiple Risk Factor Significance of silent ischemia and microalbuminuria in Intervention Trial. Diabetes Care 1993; 16: 434-44. predicting coronary events in asymptomatic patients 33.Haffner SM, Lehto S, Ronnemaa T, Pyorala K, Laakso M. with type 2 diabetes. J Am Coll Cardiol 2002; 40: 56-61. Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction. N Engl J Med 1998; 339: 229-34. 34.Redberg RF, Greenland P, Fuster V, et al. Prevention Conference VI: Diabetes and Cardiovascular Disease: Writing Group III: risk assessment in persons with diabetes. Circulation 2002; 105: e144-52. 35.Kannel WB, McGee DL. Diabetes and glucose tolerance as risk factors for cardiovascular disease: the Framingham study. Diabetes Care 1979; 2: 120-6. 36.Jacoby RM, Nesto RW. Acute myocardial infarction in the diabetic patient: pathophysiology, clinical course and prognosis. J Am Coll Cardiol 1992; 20: 736-44. 37.Juul AB, Wetterslev J, Kofoed-Enevoldsen A, Callesen T, Jensen G, Gluud C. The Diabetic Postoperative Mortality and Morbidity(DIPOM)trial: rationale and design of a multicenter, randomized, placebo-controlled, clinical trial of metoprolol for patients with diabetes mellitus who are undergoing major noncardiac surgery. Am Heart J 2004; 147: 677-83. 38.Mangano DT. Perioperative cardiac morbidity. Anesthesiology 1990; 72: 153-84. 39.Mangano DT, Wong MG, London MJ, Tubau JF, Rapp JA. Perioperative myocardial ischemia in patients undergoing noncardiac surgery-II: Incidence and severity during the 1st week after surgery. The Study of Perioperative Ischemia(SPI)Research Group. J Am Coll Cardiol 1991; 17: 851-7. 40.Janand-Delenne B, Savin B, Habib G, Bory M, Vague P, Lassmann-Vague V. Silent myocardial ischemia in patients with diabetes: who to screen. Diabetes Care 1999; 22: 1396-400. 42.Monahan TS, Shrikhande GV, Pomposelli FB, et al. Preoperative cardiac evaluation does not improve or predict perioperative or late survival in asymptomatic diabetic patients undergoing elective infrainguinal arterial reconstruction. J Vasc Surg 2005; 41: 38-45; discussion 43.Zarich SW, Cohen MC, Lane SE, et al. Routine perioperative dipyridamole 201 Tl imaging in diabetic patients undergoing vascular surgery. Diabetes Care 1996; 19: 355-60. 44.Gauss A, Rohm HJ, Schauffelen A, et al. Electrocardiographic exercise stress testing for cardiac risk assessment in patients undergoing noncardiac surgery. Anesthesiology 2001; 94: 38-46. 45.Leppo J, Plaja J, Gionet M, Tumolo J, Paraskos JA, Cutler BS. Noninvasive evaluation of cardiac risk before elective vascular surgery. J Am Coll Cardiol 1987; 9: 269-76. 46.Guidelines for assessing and managing the perioperative risk from coronary artery disease associated with major noncardiac surgery. American College of Physicians. Ann Intern Med 1997; 127: 309-12. 47.Vitola JV, Wanderley MR, Jr., Cerci RJ, et al. Outcome of patients with high-risk Duke treadmill score and normal myocardial perfusion imaging on spect. J Nucl Cardiol. 2015 Jun 3.[Epub ahead of print] 48.McPhail NV, Ruddy TD, Calvin JE, Davies RA, Barber GG. A comparison of dipyridamole-thallium imaging and exercise testing in the prediction of postoperative cardiac complications in patients requiring arterial reconstruction. J Vasc Surg 1989; 10: 51-5; discussion 5-6.